Cargando…
Reprogramming of stromal fibroblasts by SNAI2 contributes to tumor desmoplasia and ovarian cancer progression
BACKGROUND: Molecular profiling in ovarian cancer (OC) revealed that the desmoplasia subtype presented the poorest prognosis, highlighting the contribution of stromal fibroblasts in tumor progression. This study aimed to investigate the molecular characteristics of SNAI2 driving the transcriptional...
Autores principales: | Yang, Zongyuan, Yang, Xin, Xu, Sen, Jin, Ping, Li, Xiaoting, Wei, Xiao, Liu, Dan, Huang, Kecheng, Long, Sixiang, Wang, Ya, Sun, Chaoyang, Chen, Gang, Hu, Junbo, Meng, Li, Ma, Ding, Gao, Qinglei |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5645935/ https://www.ncbi.nlm.nih.gov/pubmed/29041931 http://dx.doi.org/10.1186/s12943-017-0732-6 |
Ejemplares similares
-
MARCKS contributes to stromal cancer-associated fibroblast activation and facilitates ovarian cancer metastasis
por: Yang, Zongyuan, et al.
Publicado: (2016) -
Targeting INHBA in Ovarian Cancer Cells Suppresses Cancer Xenograft Growth by Attenuating Stromal Fibroblast Activation
por: Li, Xiaoting, et al.
Publicado: (2019) -
Autophagy in stromal fibroblasts promotes tumor desmoplasia and mammary tumorigenesis
por: Rudnick, Jenny A., et al.
Publicado: (2021) -
PARP inhibitors promote stromal fibroblast activation by enhancing CCL5 autocrine signaling in ovarian cancer
por: Li, Xiaoting, et al.
Publicado: (2021) -
Mebendazole disrupts stromal desmoplasia and tumorigenesis in two models of pancreatic cancer
por: Williamson, Tara, et al.
Publicado: (2021)